728 related articles for article (PubMed ID: 19076381)
1. Opportunities and challenges in the discovery of new central nervous system drugs.
Krause JE; Chenard BL
Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
[TBL] [Abstract][Full Text] [Related]
2. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the search for drugs to treat central nervous system disorders.
Enna SJ; Williams M
J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
[TBL] [Abstract][Full Text] [Related]
4. CNS drug development: part III: future directions.
Preskorn SH
J Psychiatr Pract; 2011 Jan; 17(1):49-52. PubMed ID: 21266894
[TBL] [Abstract][Full Text] [Related]
5. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
6. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
7. Animal models of depression: challenges from a drug development perspective.
Rupniak NM
Behav Pharmacol; 2003 Sep; 14(5-6):385-90. PubMed ID: 14501252
[TBL] [Abstract][Full Text] [Related]
8. A decade of fragment-based drug design: strategic advances and lessons learned.
Hajduk PJ; Greer J
Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
[TBL] [Abstract][Full Text] [Related]
9. CNS drug development: Part II: Advances from the 1960s to the 1990s.
Preskorn SH
J Psychiatr Pract; 2010 Nov; 16(6):413-5. PubMed ID: 21107146
[TBL] [Abstract][Full Text] [Related]
10. CNS drug development. Part I: The early period of CNS drugs.
Preskorn SH
J Psychiatr Pract; 2010 Sep; 16(5):334-9. PubMed ID: 20859110
[TBL] [Abstract][Full Text] [Related]
11. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
12. Chemistry strategies in early drug discovery: an overview of recent trends.
Colombo M; Peretto I
Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial drug discovery: is it all downhill from here?
Projan SJ; Shlaes DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
[TBL] [Abstract][Full Text] [Related]
14. Systems and integrative biology as alternative guises for pharmacology: prime time for an iPharm concept?
Williams M
Biochem Pharmacol; 2005 Dec; 70(12):1707-16. PubMed ID: 16198319
[TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
16. Partnership between small biotech and big pharma.
Wiederrecht GJ; Hill RG; Beer MS
IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
[TBL] [Abstract][Full Text] [Related]
17. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
18. [Current challenges for the pharmaceutical research industry].
Chalchat B
Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
[TBL] [Abstract][Full Text] [Related]
19. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
Napper AD
IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
[No Abstract] [Full Text] [Related]
20. Opportunities and challenges in antiparasitic drug discovery.
Pink R; Hudson A; Mouriès MA; Bendig M
Nat Rev Drug Discov; 2005 Sep; 4(9):727-40. PubMed ID: 16138106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
